-
Finding (Mental) Peace this Holiday Season
The holidays are stressful enough without having to deal with lung cancer. LUNGevity is here to help. This discussion of the mental health challenges we face in the lung cancer... -
What Is a Clinical Trial
Lung cancer clinical trials are carefully designed research studies to evaluate and learn more about new drugs and treatments. They give people the ability to participate in lung... -
Watch Recorded Expert Sessions From ILCSC
The International Lung Cancer Survivorship Conference (ILCSC) is a free virtual educational conference for people with lung cancer, caregivers, and advocates. The 2023 conference... -
The Latest Lung Cancer Science: Highlights of WCLC 2023
I had the privilege of attending the 2023 World Conference on Lung Cancer (WCLC) in Singapore with my colleague Dr. Bellinda King-Kallimanis. WCLC, the world's largest meeting... -
Lung Cancer and NCCN Guidelines: What They Are and Why They Matter
In this expert meetup session, Carlin Callaway will review the National Comprehensive Cancer Network’s (NCCN’s) Non-Small Cell Lung Cancer (NSCLC) Guidelines and discuss how they... -
Be Part of the Largest Lung Cancer Event in the Nation
November is Lung Cancer Awareness Month, when the lung cancer community gathers to raise awareness for this disease and stand together – unified and strong. You can get involved in... -
Transportation to Treatment
At some point, transportation to appointments becomes a challenge for everyone. Whether it be the cost, time commitment, or finding reliable transportation, we share some tips for... -
Laurie’s Path to Finding the Right Doctor, the Right Test, and the Right Treatment
Laurie Seligman, a 57-year-old bookkeeper living in Texas, had a lingering cough, but over-the-counter cough syrup seemed to help, so she didn’t think much of it and she continued... -
Decentralized Trials: Bringing Clinical Trials Closer to the Patient
While participating in clinical trials can provide substantial benefits to people with lung cancer, the resources required to do so may pose significant hurdles, especially to... -
LUNGevity's International Lung Cancer Survivorship Conference
LUNGevity's 2023 International Lung Cancer Survivorship Conference features something for everyone! Our lineup of internationally renowned lung cancer experts will be covering a... -
We have succeeded in targeting KRAS G12C mutations. Now what?
We currently have two FDA-approved drugs, sotorasib and adagrasib, that are used to treat advanced-stage NSCLC with KRAS G12C mutations. Watch the discussion with guest speakers... -
2023 ASCO: Highlights of Lung Cancer Research
Recently, members of LUNGevity Foundation joined thousands of attendees from the US and around the world, including oncologists, scientists, biotech and pharmaceutical...
KRAS